4/1
08:01 am
mynz
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
High
Report
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
3/27
09:01 am
mynz
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
High
Report
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
3/13
08:01 am
mynz
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Medium
Report
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
3/3
08:01 am
mynz
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
Medium
Report
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
2/20
08:01 am
mynz
Mainz Biomed Expands into Switzerland with labor team w
Low
Report
Mainz Biomed Expands into Switzerland with labor team w
2/14
08:16 am
mynz
Mainz Biomed (NASDAQ: MYNZ) is now covered by analysts at Maxim Group. They set a "buy" rating and a $14.00 price target on the stock.
Medium
Report
Mainz Biomed (NASDAQ: MYNZ) is now covered by analysts at Maxim Group. They set a "buy" rating and a $14.00 price target on the stock.
2/11
08:01 am
mynz
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
High
Report
Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
1/27
08:01 am
mynz
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
Medium
Report
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
1/21
08:01 am
mynz
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
Low
Report
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population